A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Indevus Pharmaceuticals

About Indevus Pharmaceuticals

Indevus acquires, develop and commercialize products for multiple theraputic areas, with a primary commitment to urology, gynecology and infectious diseases.

With the recent launch of their lead product, SANCTURA™ for overactive bladder, they have established a sales and marketing infrastructure. They believe this expansion positions them strongly as a partner of choice for companies and research institutions seeking a collaborator with the proven ability to accomplish the development and commercialization of a broad array of biopharmaceutical products in a timely and efficient manner.


Pieline for Indevus


SANCTURA -- Overactive Bladder -- Marketed

Pagoclone-- Anxiety and Stuttering

PRO2000-- HIV and STD Prevention

IP751 -- Pain and Inflammation

Aminocandin -- Fungal Infection

Sarafem -- Premenstrual Dysphoric Disorder -- Marketed



More on Indevus

Home Page

Key Statistics for Indevus

Basic Chart for Indevus

Analyst Opinion

Analysts Estimates


Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.